Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines

H Gao1, Q Song2, J Yang2

  • 1Department of Urology, the Dalian Central Hospital, Dalian, China.

Insights

Carnosol inhibits prostate cancer cell growth and induces apoptosis by downregulating the Hedgehog (HH) signaling pathway. This compound shows potential as a therapeutic agent, particularly for hormone-independent prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The Hedgehog (HH) signaling pathway is implicated in prostate cancer development.
  • Understanding the molecular mechanisms of prostate cancer is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the effect of carnosol on the Hedgehog (HH) signaling pathway in human prostate cancer cells.
  • To evaluate carnosol's potential as a therapeutic agent for both hormone-dependent and hormone-independent prostate cancer.

Main Methods:

  • Immunohistochemistry was used to detect Gli1 and Shh expression in prostate cancer tissues.
  • MTT assay, qRT-PCR, and Western blot were employed to assess cell survival and gene/protein expression.
  • Caspase-3 activity assay was performed to determine apoptosis levels.

Main Results:

  • Sonic hedgehog (Shh) and glioma-associated oncogene homolog 1 (Gli1) were upregulated in prostate cancer tissues.
  • Carnosol inhibited cell survival and proliferation in both LNCaP and DU145 cell lines in a dose-dependent manner.
  • Carnosol downregulated Shh and Gli1 expression and increased caspase-3 activity, indicating apoptosis induction.

Conclusions:

  • Carnosol inhibits prostate cancer cell proliferation and induces apoptosis, potentially through the inhibition of the HH signaling pathway.
  • While carnosol demonstrated stronger effects on hormone-dependent cells, it shows promise as a therapeutic agent for hormone-independent prostate cancer.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K